Ultrastructural changes in a rat model of lower limb ischemia/reperfusion injury undergoing edaravone

doi:10.3969/j.issn.2095-4344.2014.18.014

Abstract

Abstract:

BACKGROUND: The oxygen free radicals and apoptosis play an important role in limb ischemia/reperfusion injury, so we can alleviate limb ischemia/reperfusion injury by inhibiting the production of oxygen free radicals and apoptosis.
OBJECTIVE: To discuss the application and effect of edaravone on limb ischemia/reperfusion injury in rats.
METHODS: Of the 30 female Sprague-Dawley rats, 20 rats were randomly selected to make models of limb ischemia/reperfusion injury by ligating the root of right lower limb with a self-made balloon cuff at 40 kPa pressure to block blood flow for 4 hours and reperfusing. After success model establishment, they were randomly assigned to two groups. In the edaravone perfusion group, edaravone 3 mg/kg was injected via the left femoral vein at 5 minutes before reperfusion. In the model group and normal group (the remaining 10 rats), an equal volume of physiological saline was given at the same time point. At 24 hours after reperfusion, the right anterior tibial muscle of each group was removed and these ultrastructural changes were observed by transmission electron microscope. Bcl-2 mRNA and Bax mRNA of rat anterior tibial muscle of each group were semiquantitatively detected with the RT-PCR and the ratio of bcl-2/bax was calculated.
RESULTS AND CONCLUSION: (1)Electron microscope results: compared with the model group, the muscle fibers were neater; the M line and the N line were clearer; the swelling of mitochondria was alleviated; the numbers of mitochondria and mitochondrial crista were also increased in the edaravone perfusion group. (2)RT-PCR results: At 24 hours after reperfusion, the relative expression of bcl-2 mRNA and the ratio of bcl-2 mRNA to bax mRNA in right anterior tibial muscle were lower in the model group compared with the edaravone perfusion group (P < 0.05). However, relative expression of bax mRNA was greater in the model group than that in the edaravone perfusion group, which were both higher than the normal group (P < 0.05). Results indicated that the free radical scavenger edaravone relieved limb ischemia/reperfusion injury by improving the mitochondrial ultrastructure and promoting expression of bcl-2 mRNA and inhibiting expression of bax mRNA, and could provide a new choice for the treatment of limb ischemia/reperfusion injury.

中国组织工程研究杂志出版内容重点：肾移植；肝移植；移植；心脏移植；组织移植；皮肤移植；皮瓣移植；血管移植；器官移植；组织工程

全文链接：

Key words: reperfusion injury, lower extremity, free radical scavengers, cell death

CLC Number:

R318

Dong Su-ming, Chang Wen-kai, Luo Jun-qian, Xue Jia-jie, Jia Ying-wei, Liang Bing-sheng. Ultrastructural changes in a rat model of lower limb ischemia/reperfusion injury undergoing edaravone[J]. Chinese Journal of Tissue Engineering Research, 2014, 18(18): 2867-2871.

Figures/Tables 2

References

[1] 郑灿镔,朱庆棠,顾立强,等.四肢主要动脉钝性损伤的伤情特点分析[J].中华损伤与修复杂志:电子版, 2011, 6(4): 013.
[2] 陈主初,郭恒怡,王树人.病理生理学[M].北京:人民卫生出版社, 2005:190-191.
[3] Gillani S, Cao J, Suzuki T, et al. The effect of ischemia reperfusion injury on skeletal muscle. Injury.2012;43(6): 670-675.
[4] 孙德舜,韩继明,王小鹤,等.肢体缺血再灌注损伤的研究进展[J].中国骨伤, 2004,17(7): 446-448.
[5] Hsieh CH, Jeng JC, Jeng SF, et al. MicroRNA profiling in ischemic injury of the gracilis muscle in rats. BMC Musculoskelet Disord. 2010;11(1): 123.
[6] Gyurkovics E,Aranyi P,Stangl R,et al.Postconditioning of the lower limb—protection against the reperfusion syndrome. J Surg Res. 2011;169(1):139-147.
[7] Bolcal C, Yildirim V, Doganci S,et al.Protective effects of antioxidant medications on limb ischemia reperfusion injury. J Surg Res. 2007;139(2):274-279.
[8] Irie H, Kato T, Ikebe K, et al. Antioxidant effect of MCI-186, a new Free-Radical scavenger, on ischemia-reperfusion injury in a rat hindlimb amputation model. J Surg Res.2004;120(2): 312-319.
[9] Kikuchi K, Uchikado H, Miyagi N, et al. Beyond neurological disease: New targets for edaravone (Review). Int J Mol Med. 2011;28(6):899-906.
[10] Tonon J, Cecchini AL, Brunnquell CR, et al. Lung injury-dependent oxidative status and chymotrypsin-like activity of skeletal muscles in hamsters with experimental emphysema. BMC musculoskelet disord.2013；14(1): 39.
[11] Qi X, Okuma Y, Hosoi T, et al. Edaravone protects against hypoxia/ischemia-induced endoplasmic reticulum dysfunction. J Pharmacol Exp Ther. 2004;311(1):388-393.
[12] Kikuchi K, Takeshige N, Miura N, et al. Beyond free radical scavenging: Beneficial effects of edaravone (Radicut) in various diseases (Review). Exp Therapeutic Med.2012;3(1): 3-8.
[13] Lee BJ, Egi Y, van Leyen K, et al. Edaravone, a free radical scavenger, protects components of the neurovascular unit against oxidative stress in vitro. Brain Res. 2010;1307: 22-27.
[14] Wu S, Sena E, Egan K, et al. Edaravone improves functional and structural outcomes in animal models of focal cerebral ischemia: A systematic review. International J Stroke.2014; 9(1): 101-106.
[15] 张连元,杨林．生理科学实验教程[M]北京:人民军医出版社, 2001:29-30．
[16] 胡跃林,于长隆,钟炎丰,等.止血带缺血预处理对大鼠骨骼肌缺血再灌注损伤的保护作用——组织病理学研究[J].中国运动医学杂志, 2003, 22(2):153-155.
[17] Pfaffl MW. A new mathematical model for relative quantification in real-time RT–PCR. Nucleic Acids Res. 2001; 29(9): e45-e45.
[18] 段永壮,王增涛,钟世镇,等.依达拉奉对深低温保存大鼠断肢再植后缺血再灌注损伤的影响[J].中国组织工程研究与临床康复, 2007,11(8):1416-1418.
[19] Iida H, Nagasaka T,Shindo K,et al.Effect of the free radical scavenger edaravone on peripheral nerve ischemia-reperfusion injury. Muscle & Nerve.2009;40(4): 582-588.
[20] Crawford RS, Hashmi FF, Jones JE, et al. A novel model of acute murine hindlimb ischemia. Am J Physiol Heart Circ Physiol. 2007;292(2):H830-H837.
[21] 邢宏昶,姚鲲,侯磊,等.依那普利后处理对肢体缺血再灌注诱发大鼠心肌损伤的影响[J].中华麻醉学杂志, 2013, 33(3): 360-362.
[22] 张敬东,易先宏,李玉安.缺血再灌流股骨头骺影响关节软骨细胞的凋亡[J].中国组织工程研究, 2013, 17(28): 5133-5138.
[23] Pommier Y,Sordet O,Antony S,et al.Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks. Oncogene.2004；23(16): 2934-2949.
[24] Jena S, Chainy G B N, Dandapat J. Expression of antioxidant genes in renal cortex of PTU-induced hypothyroid rats: effect of vitamin E and curcumin.Mol Biol Rep. 2012;39(2):1193- 1203.
[25] Grinberg M, Schwarz M, Zaltsman Y, et al. Mitochondrial carrier homolog 2 is a target of tBID in cells signaled to die by tumor necrosis factor alpha. Molecular and cellular biology. 2005;25(11): 4579-4590.
[26] Chami M, Prandini A, Campanella M, et al. Bcl-2 and Bax exert opposing eff ects on Ca2+ signaling, which do not depend on their putative pore-forming region. J Biol Chem. 2004;279(52):54581-54589.
[27] 谷造华,冯小宁,李永平,等. miRNA-1 和 miRNA-133 在大鼠失神经腓肠肌中的变化规律研究[J].中华细胞与干细胞杂志:电子版,2013, 3(1): 17-20.
[28] 沈燕国,徐建光,顾玉东,等.人体失神经支配骨骼肌 1Na, K-ATP 酶, Ca-ATP 酶及糖原的变化[J]. 复旦学报:医学版, 2002, 29(5): 343-346.
[29] Hori K,Tsujii M,Iino T,et al.Protective effect of edaravone for tourniquet-induced ischemia-reperfusion injury on skeletal muscle in murine hindlimb. BMC Musculoskelet Disord.2013；14(1): 113.
[30] Rajesh KG,Sasaguri S,Suzuki R,et al.Antioxidant MCI-186 inhibits mitochondrial permeability transition pore and upregulates Bcl-2 expression.Am J Physiol Heart Circ Physiol. 2003; 285(5): H2171-H2178.
[31] Liang H, Yu F, Tong Z, et al. Effect of ischemia post-conditioning on skeletal muscle oxidative injury, mTOR, Bax, Bcl-2 proteins expression, and HIF-1α/β-actin mRNA,IL-6/β-actin mRNA and caveolin-3/β-actin mRNA expression in ischemia-reperfusion rabbits. Molecular biology reports.2013;40(1): 507-514.